Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AstraZeneca Calls For Newly Approved Drugs To Carry Symbol In Labeling

This article was originally published in The Pink Sheet Daily

Executive Summary

A white paper released by the company argues against an "arbitrary" DTC moratorium on new drugs.

You may also be interested in...



AstraZeneca Rx Promotions Subject Of U.S. Attorney Investigation

The Los Angeles U.S. Attorney’s Office is examining the company’s local field promotions.

AstraZeneca Rx Promotions Subject Of U.S. Attorney Investigation

The Los Angeles U.S. Attorney’s Office is examining the company’s local field promotions.

Pfizer Guidelines Call For Physician Education For Six Months Prior To DTC

Stay on DTC is more specific than PhRMA’s DTC guiding principles, which require an “appropriate amount of time” be spent on physician education prior to campaign launch.

Topics

UsernamePublicRestriction

Register

PS061230

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel